David Epstein, Ph.D.
Board Member
Gyre Therapeutics, Inc. (GYRE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Epstein, Ph.D.
David Epstein, Ph.D. is recorded as Board Member at Gyre Therapeutics, Inc. (GYRE). Gyre Therapeutics, Inc. reported in an 8-K filed August 8, 2024 that David Epstein, Ph.D. was appointed Class II director, effective August 6, 2024.
“On August 6, 2024, the Board of Directors (the "Board") of Gyre Therapeutics, Inc. (the "Company") appointed David Epstein, Ph.D. as a Class II director to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Gyre Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Charles Wu CEO, Board Member
- Dr. Han Ying CEO
- Dr. Ying Luo CEO, Board Member
- Ping Zhang CEO, Board Member
- Ying Luo CEO, Board Member
- Ying Luo, Ph.D. CEO, Board Member
- Augustine Lawlor Chairman, Board Member
- Songjiang Ma Chairman, Board Member
- Clinton Musil CFO
- Fletcher Payne CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.